Modified peroxamide-based reactive oxygen species (ROS)-responsive doxorubicin prodrugs
Mina Jafari, Vishnu Sriram, Gurdat Premnauth, Edward J. Merino, Joo‐Youp Lee
Topics & Concepts
ProdrugReactive oxygen speciesChemistryDoxorubicinClonogenic assayIntracellularPharmacologyCytotoxicityCell cultureViability assayCancer researchBiochemistryCellIn vitroChemotherapyBiologyMedicineInternal medicineGeneticsNanoplatforms for cancer theranosticsNanoparticle-Based Drug DeliveryAdvanced Nanomaterials in Catalysis